Pleiotropic Effects of Platelet P2Y12 Receptor Inhibitors: Fact or Fiction?

被引：5
|
作者：
Moulias, Athanasios [1 ]
Xanthopoulou, Ioanna [1 ]
Alexopoulos, Dimitrios [1 ]
机构：
[1] Patras Univ Hosp, Dept Cardiol, Patras 26500, Greece
来源：
CURRENT PHARMACEUTICAL DESIGN | 2014年 / 20卷 / 28期
关键词：
Clopidogrel; off-target effects; pleiotropic; P2Y12; inhibitors; prasugrel; ticagrelor; CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; P-SELECTIN EXPRESSION; C-REACTIVE PROTEIN; INFLAMMATORY MARKERS; ACTIVE METABOLITE; ADENOSINE-DIPHOSPHATE; CLOPIDOGREL PRETREATMENT; ANTIPLATELET THERAPY; ENDOTHELIAL FUNCTION;
D O I：
10.2174/1381612820666140414211543
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P2Y(12) inhibitors constitute an essential part of the antithrombotic treatment, with proven clinical benefit in acute coronary syndromes and after percutaneous coronary interventions. Substantial evidence has emerged that, apart from their primary antiplatelet action, P2Y(12) receptor inhibitors exhibit several off-target effects. In this review, we present the supporting evidence of P2Y(12) inhibitors' pleiotropic actions, discuss their clinical implications and underscore the necessity for further research on this issue.
引用
收藏
页码：4597 / 4604
页数：8
相关论文
共 50 条
  • [1] Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors
    Adamski, Piotr
    Kozinski, Marek
    Ostrowska, Malgorzata
    Fabiszak, Tomasz
    Navarese, Eliano Pio
    Paciorek, Przemyslaw
    Grzesk, Grzegorz
    Kubica, Jacek
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (02) : 224 - 242
  • [2] P2Y12 receptor in platelet activation
    Kim, Soochong
    Kunapuli, Satya P.
    PLATELETS, 2011, 22 (01) : 56 - 60
  • [3] Pharmacology of the platelet P2Y12 receptor
    von Kuegelgen, Ivar
    PURINERGIC SIGNALLING, 2018, 14 : S8 - S9
  • [4] Pharmacogenetics of P2Y12 receptor inhibitors
    Thomas, Cameron D. D.
    Williams, Alexis K. K.
    Lee, Craig R. R.
    Cavallari, Larisa H. H.
    PHARMACOTHERAPY, 2023, 43 (02): : 158 - 175
  • [5] Responsiveness to P2Y12 receptor inhibitors
    Esposito, Giovanni
    CURRENT OPINION IN CARDIOLOGY, 2011, 26 : S31 - S37
  • [6] Adenosine analogues as inhibitors of P2Y12 receptor mediated platelet aggregation
    Douglass, James G.
    deCamp, J. Bryan
    Fulcher, Emilee H.
    Jones, William
    Mahanty, Sanjoy
    Morgan, Anna
    Smirnov, Dima
    Boyer, Jose L.
    Watson, Paul S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 2167 - 2171
  • [7] The Function and Regulation of Platelet P2Y12 Receptor
    Li, Xiaohua
    Zhang, Guoxing
    Cao, Xia
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (01) : 199 - 216
  • [8] Biology and pharmacology of the platelet P2Y12 receptor
    Storey, Robert F.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (10) : 1255 - 1259
  • [9] The Function and Regulation of Platelet P2Y12 Receptor
    Xiaohua Li
    Guoxing Zhang
    Xia Cao
    Cardiovascular Drugs and Therapy, 2023, 37 : 199 - 216
  • [10] Insights into platelet P2Y12 receptor activation
    Nicholas, Robert A.
    BLOOD, 2015, 125 (06) : 893 - 895
12345